Eastpharma Ltd GDR (LSE:EAST) - Share price - Overview

Stock Report

Eastpharma Ltd EAST

Last Price
$-

Day Change
-|-%

As of -
- | USD
Minimum 15 Minutes Delay.

Last Close-
Day Range-
Mkt Cap67.65Mil
52-Wk Range-
Yield %-
ISINUS27778Q2049
Volume-
P/E-
P/S-
P/CF-

Share Price

Total Returns 18/05/2018

 Chg (%)  
More ...
Eastpharma Ltd0.00 
FTSE 100 TR GBP1.29
 
Financials
201520162017
More ...
Income Statement
Turnover209.89224.92220.43
Operating Profit31.1639.0842.62
Net Profit11.3218.4727.82
Reported EPS0.130.230.35
Balance Sheet
Current Assets170.36137.57176.47
Non Current Assets282.68259.75267.10
Total Assets453.05397.32443.57
Current Liabilities161.3573.85114.97
Total Liabilities187.72147.58176.71
Total Equity265.33249.73266.86
Cash Flow
Operating Cash Flow32.9055.7027.10
Net Change in Cash-8.71-5.3511.44

Company Profile

Eastpharma Ltd is a pharmaceutical company engaged in manufacturing and marketing of branded and in-licensed generic pharmaceuticals in Turkey and other regional markets. It has a wide range of product portfolio and a country-wide organized sales force.

Sector

Drug Manufacturers - Major

Index

Next Event 10/08/2018

Half-Yearly Results
Ratios
Comp
More ...
PER (E)2.86
Div Yld (E)0.00
PEG (E)0.00
ROCE13.76
Op Mrgn0.19
EPS Grwth0.42
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Executive DirectorJohn Coombe-Tennant BA
Executive DirectorPeter Baird CFA,BA,MA,MBA
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.